New publication in HemaSphere

This study evaluated vitamin K antagonist (VKA) anticoagulation control during the last year of life, using nationwide data from Statistics Netherlands, linked to anticoagulation clinics’ data and the Netherlands Cancer Registry.

Quality of vitamin K antagonist treatment during the last year of life